Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 8:56 pm Sale | 2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Venrock Healthcare Capital Partners III, L.P. | 925,048 2.800% | -1,283,764 (-58.12%) | Filing |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Venrock Healthcare Capital Partners III, L.P. | 2,208,812 6.400% | 136,803 (+6.60%) | Filing |
| 2022-09-19 9:14 pm Purchase | 2022-09-09 | 13G | Milestone Pharmaceuticals Inc. MIST | Venrock Healthcare Capital Partners III, L.P. | 2,072,009 6.900% | 2,072,009 (New Position) | Filing |